Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study

OBJECTIVES: Data about the efficacy of ertapenem for the treatment of bloodstream infections (BSI) due to ESBL-producing Enterobacteriaceae (ESBL-E) are limited. We compared the clinical efficacy of ertapenem and other carbapenems in monomicrobial BSI due to ESBL-E. METHODS: A multinational retrospe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Antimicrob Chemother
Autors principals: Gutiérrez-Gutiérrez, Belén, Bonomo, Robert A., Carmeli, Yehuda, Paterson, David L., Almirante, Benito, Martínez-Martínez, Luis, Oliver, Antonio, Calbo, Esther, Peña, Carmen, Akova, Murat, Pitout, Johann, Origüen, Julia, Pintado, Vicente, García-Vázquez, Elisa, Gasch, Oriol, Hamprecht, Axel, Prim, Nuria, Tumbarello, Mario, Bou, German, Viale, Pierluigi, Tacconelli, Evelina, Almela, Manel, Pérez, Federico, Giamarellou, Helen, Cisneros, José Miguel, Schwaber, Mitchell J., Venditti, Mario, Lowman, Warren, Bermejo, Joaquín, Hsueh, Po-Ren, Mora-Rillo, Marta, Gracia-Ahulfinger, Irene, Pascual, Alvaro, Rodríguez-Baño, Jesús
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4867097/
https://ncbi.nlm.nih.gov/pubmed/26907184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkv502
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars